NEW YORK – MiLaboratories and MIODx today announced an agreement to collaborate on products and services related to immune repertoire profiling.
Under the terms of the agreement, the companies will offer contract research services to the US and European markets in "all applications related to sequencing-based probing of human and animal adaptive immune systems," the firms said in a statement.
MIODx will carry out wet lab services in its San Jose, California facilities.
Contract research projects will use MiLaboratories' kits for human and mouse T cell receptor and B cell receptor profiling, with basic data analysis run on its ImmunoCloud platform. The firm will also provide advanced data analysis using a proprietary cloud solution, its MiXCR bioinformatics suite, its MiNNN molecular barcoding technology, VDJtools software, and custom bioinformatics analysis.
"This agreement will help us to substantially broaden the scope and geography of our service offering in the increasingly important and competitive area of immune profiling," Yuri Nikolsky, MiLaboratories CEO, said in a statement. "Collaboration with MIODx will allow us to expand our offering, utilizing our unique expertise in molecular barcoding, single-cell sequencing applications, library construction, and other key elements of the immunosequencing pipeline."
Financial and other details of the agreement were not disclosed.